Skip to content

Opening book details…

Can I read Reimagining Druggability Using Chemoproteomic Platforms on EtoBox?

Reimagining Druggability Using Chemoproteomic Platforms by Jessica N. Spradlin; Erika Zhang; Daniel K. Nomura is a Chemistry article available to read on EtoBox.

What is Reimagining Druggability Using Chemoproteomic Platforms about?

## Metrics & More Article Recommendations CONSPECTUS: One of the biggest bottlenecks in modern drug discovery efforts is in tackling the undruggable proteome. Currently, over 85% of the proteome is still considered undruggable because most proteins lack well-defined binding pockets that can be functionally targeted with small molecules. Tackling the undruggable proteome necessitates innovative approaches for ligand discovery against undruggable proteins as well as the development of new therapeutic modalities to functionally manipulate proteins of interest. Chemoproteomic platforms, in particular activity-based protein profiling (ABPP), have arisen to tackle the undruggable proteome by using reactivity-based chemical probes and advanced quantitative mass spectrometry-based proteomic approaches to enable the discovery of "ligandable hotspots" or proteome-wide sites that can be targeted with small-molecule ligands. These sites can subsequently be pharmacologically targeted with covalent ligands to rapidly discover functional or nonfunctional binders against therapeutic proteins of interest. Chemoproteomic approaches have also revealed unique insights into ligandability such as the di

Who reads Reimagining Druggability Using Chemoproteomic Platforms?

It is typically read by researchers, students, and practitioners in Chemistry.

Author
Jessica N. Spradlin; Erika Zhang; Daniel K. Nomura
Publisher
American Chemical Society (ACS)
Published
2021
Language
EN
Field
Chemistry (Physical Sciences)

More by Jessica N. Spradlin; Erika Zhang; Daniel K. Nomura

Browse all works by Jessica N. Spradlin; Erika Zhang; Daniel K. Nomura